Seres Therapeutics
is a Massachusetts-based biotechnology company that researches and develops novel microbiome therapeutics for the treatment of gastrointestinal infections... Read moreSeres Therapeutics
is a Massachusetts-based biotechnology company that researches and develops novel microbiome therapeutics for the treatment of gastrointestinal infections... Read more
News
Apr 23, 2025
Yahoo
Seres Therapeutics: Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
Mar 14, 2025
Owler
Seres Therapeutics, Inc.: Seres Therapeutics's employee count changed from 233 in Dec 2023 to 103 in Dec 2024
Mar 13, 2025
Seeking Alpha
Seres Therapeutics: Seres Therapeutics GAAP EPS of -$0.81 misses by $0.69
Mar 04, 2025
Marketscreener
Seres Therapeutics: Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025
Mar 03, 2025
GlobalNewswire
Press Release: Seres Therapeutics : Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
Jan 16, 2025
Nasdaq
Seres Therapeutics: Seres Receives $50 Mln Installment Payment Towards Sale Of VOWST Business To Nestle Health Science
Jan 09, 2025
StreetInsider
Press Release: Seres Therapeutics : Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates
Dec 16, 2024
Benzinga
Seres Therapeutics: Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
Dec 10, 2024
Pharamceutical Technology
Seres Therapeutics: Seres' SER-155 gains breakthrough status for BSIs reduction
Nov 22, 2024
Benzinga
Seres Therapeutics: Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
Seres Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10